- Home
- PED vs FATE Comparison
PED vs FATE Comparison
Compare PED & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PED | FATE |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.8M | 125.6M |
| IPO Year | 2012 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PED | FATE |
|---|---|---|
| Price | $14.33 | $2.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $30.00 | $4.10 |
| AVG Volume (30 Days) | 17.3K | ★ 1.5M |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $45,751,000.00 | $6,646,000.00 |
| Revenue This Year | $171.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.67 | N/A |
| 52 Week Low | $0.43 | $0.93 |
| 52 Week High | $18.89 | $3.23 |
Technical Indicators
Market Signals| Indicator | PED | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 62.91 | 44.71 |
| Support Level | $12.89 | $2.24 |
| Resistance Level | $16.70 | $2.88 |
| Average True Range (ATR) | 0.64 | 0.14 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 85.29 | 38.30 |
Price Performance
Historical ComparisonAbout PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.